PUBLISHER: The Business Research Company | PRODUCT CODE: 1509615
PUBLISHER: The Business Research Company | PRODUCT CODE: 1509615
Cough remedies are treatments or methods used to alleviate symptoms associated with coughing, such as irritation, inflammation, or congestion in the respiratory tract. These remedies aim to provide relief from common respiratory issues, reducing the urge to cough and including expectorants to help expel mucus from the airways.
The main product types of cough remedies include expectorants, antihistamines, bronchodilators, decongestants, and antibiotics. Expectorants are medications or natural ingredients that help clear mucus from a person's airways. The various dosage forms include oral syrups, tablets or pills, nasal drops, and lozenges. These remedies are used by various age groups, including pediatric and adult populations, and are distributed through various channels such as retail pharmacies, hospital pharmacies, and others.
The cough remedies market research report is one of a series of new reports from The Business Research Company that provides cough remedies market statistics, including cough remedies industry global market size, regional shares, competitors with a cough remedies market share, detailed cough remedies market segments, market trends and opportunities, and any further data you may need to thrive in the cough remedies industry. This cough remedies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cough remedies market size has grown strongly in recent years. It will grow from $10.19 billion in 2023 to $11.06 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising government healthcare expenditure, growing awareness of natural cough remedies, and increased vehicle emissions.
The cough remedies market size is expected to see strong growth in the next few years. It will grow to $15.44 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to the rising prevalence of respiratory diseases, a growing geriatric population, innovation in cough treatments, high demand for over-the-counter (OTC) products, increasing air pollution, and growing awareness of self-care. Major trends in the forecast period include investments, company partnerships, and innovations in lozenges and cough candies.
The increasing prevalence of respiratory diseases is expected to drive the growth of the cough remedies market in the future. Respiratory diseases encompass various conditions affecting the organs involved in breathing and gas exchange in air-breathing animals. The uptick in respiratory ailments is attributed to heightened exposure to environmental pollutants, overcrowded living conditions, and increased vehicle emissions. Cough remedies, including expectorants, assist in thinning mucus in the airways, facilitating easier clearance through coughing. This can alleviate discomfort and promote healing, particularly in individuals with sore throats or irritated airways. For example, in 2021, as reported by the National Centre for Environmental Health, approximately 25 million people (7.7% of the U.S. population) had asthma, marking an increase from 20.3 million, or 7.4%, compared to the previous decade. Moreover, in June 2023, the American Lungs Association stated that about 15.6 million adults (6.4 percent) reported ever being diagnosed with COPD in 2021. Hence, the rising incidence of respiratory diseases fuels the cough remedies market.
Major companies in the cough remedies market are innovating their product lines, introducing herbal cough syrups to enhance offerings and improve treatment processes. Herbal cough syrup, derived from natural plant ingredients known for their soothing and expectorant properties, is gaining prominence. For instance, in April 2021, Ernest, a pharmaceutical company based in Ghana, launched HoneyKof Herbal Cough Syrup. This non-drowsy, sugar-free syrup, based on honey, provides swift relief from cough, sore throat, and throat irritation. Its formulation includes natural ingredients such as honey, ginger, basil leaves, violets, long pepper, and liquorice, which have long been trusted as remedies.
In June 2023, GSK plc, a UK-based pharmaceutical company, acquired BELLUS Health Inc. for an undisclosed sum. This acquisition bolsters GSK's portfolio of specialty medicines and strengthens its expertise in respiratory therapies with BELLUS's promising P2X3 antagonist, currently in phase III development for the first-line treatment of adult patients with refractory chronic cough (RCC). BELLUS Health Inc. is a Canada-based company specializing in novel therapeutics for chronic cough treatment.
Major companies operating in the cough remedies market are Pfizer Inc., The Procter & Gamble Company (P&G), Johnson & Johnson Inc., Merck & Co. Inc., Bayer AG, Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Reckitt Benckiser Group, Perrigo Lab India Private Limited, Prestige Brands Holdings Inc., Hyland's Inc., Boiron, Chattem Chemicals Inc., Tris Pharma Inc., Mayne Pharma Inc., Zarbee's Inc., Genexa Inc.
North America was the largest region in the cough remedies market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cough remedies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cough remedies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The cough remedies market consists of sales of natural remedy products, cough suppressants, and over-the-counter remedies. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cough Remedies Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on cough remedies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cough remedies? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cough remedies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.